MDR multidrug resistance
MDR (multidrug resistance) is a property that first identified in tumor cell, hat the resistance of tumor cell is to a variety of chemotherapy agent due to active efflux via transporter proteins.
Products Related to MDR multidrug resistance(44)
- GC46809Afatinib-d6CAS: 1313874-96-2Purity: >99.00%
An internal standard for the quantification of afatinib
- GC48119SuprafenacineCAS: 1477482-50-0Purity: >98.00%
An inhibitor of tubulin polymerization with anticancer activity
- GC48219Ulipristal Acetate-d6CAS: 1621894-64-1Purity: >99.00%
An internal standard for the quantification of ulipristal acetate
- GC48479MigrastatinCAS: 314245-65-3Purity: >90.00%
A fungal metabolite with antimuscarinic and anticancer activities
- GC49251Oxaliplatin-d10CAS: 1132819-16-9Purity: >99.00%
An internal standard for the quantification of oxaliplatin
- GC492758-OxycoptisineCAS: 19716-61-1Purity: >98.00%
8-Oxycoptisine is a natural protoberberine alkaloid with anti-cancer activity.
- GC49308UngeremineCAS: 2121-12-2Purity: >98.00%
A betaine-type alkaloid with diverse biological activities
- GC52104Ponatinib (hydrochloride)CAS: 1114544-31-8Purity: >98.00%
Ponatinib (hydrochloride) is a multi-target tyrosine kinase inhibitor that inhibits the activity of Abl (IC₅₀=0.37nM), PDGFRα (IC₅₀=1.1nM), VEGFR2 (IC₅₀=1.5nM), FGFR1 (IC₅₀=2.2nM), and Src (IC₅₀=5.4nM).
- GC52455Pixantrone-d8 (maleate)Purity: >99.00%
An internal standard for the quantification of pixantrone
- GC90543EGFR Peptide (human, mouse) (myristoylated) (trifluoroacetate salt)Purity: >95.00%
A PKC inhibitor
- GC911354-(3,4-Difluorobenzo)curcuminCAS: 1170354-22-9Purity: >95.00%
A semisynthetic coumarin with antiparasitic and anticancer activities
- GC91152Flavokawain 1iCAS: 1098176-51-2Purity: >98.00%
A flavokawain derivative with anticancer and antiviral activities
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC46809 | Afatinib-d6 | 1313874-96-2 | >99.00% | |
An internal standard for the quantification of afatinib | ||||
| GC48119 | Suprafenacine | 1477482-50-0 | >98.00% | |
An inhibitor of tubulin polymerization with anticancer activity | ||||
| GC48219 | Ulipristal Acetate-d6 | 1621894-64-1 | >99.00% | |
An internal standard for the quantification of ulipristal acetate | ||||
| GC48479 | Migrastatin | 314245-65-3 | >90.00% | |
A fungal metabolite with antimuscarinic and anticancer activities | ||||
| GC49106 | Gentisein | 529-49-7 | >95.00% | |
A xanthone with diverse biological activities | ||||
| GC49251 | Oxaliplatin-d10 | 1132819-16-9 | >99.00% | |
An internal standard for the quantification of oxaliplatin | ||||
| GC49275 | 8-Oxycoptisine | 19716-61-1 | >98.00% | |
8-Oxycoptisine is a natural protoberberine alkaloid with anti-cancer activity. | ||||
| GC49308 | Ungeremine | 2121-12-2 | >98.00% | |
A betaine-type alkaloid with diverse biological activities | ||||
| GC49670 | Indium (III) thiosemicarbazone 5b | 2345755-20-4 | >95.00% | |
An anticancer agent | ||||
| GC52104 | Ponatinib (hydrochloride) | 1114544-31-8 | >98.00% | |
Ponatinib (hydrochloride) is a multi-target tyrosine kinase inhibitor that inhibits the activity of Abl (IC₅₀=0.37nM), PDGFRα (IC₅₀=1.1nM), VEGFR2 (IC₅₀=1.5nM), FGFR1 (IC₅₀=2.2nM), and Src (IC₅₀=5.4nM). | ||||
| GC52455 | Pixantrone-d8 (maleate) | - | >99.00% | |
An internal standard for the quantification of pixantrone | ||||
| GC90543 | EGFR Peptide (human, mouse) (myristoylated) (trifluoroacetate salt) | - | >95.00% | |
A PKC inhibitor | ||||
| GC90660 | Fz25 | 2762498-70-2 | >98.00% | |
A triazole-modified sterol and an anticancer agent | ||||
| GC91057 | HP661 | - | >98.00% | |
A mitochondrial complex I inhibitor | ||||
| GC91096 | S-72 | 2446799-14-8 | >98.00% | |
An inhibitor of microtubule polymerization | ||||
| GC91135 | 4-(3,4-Difluorobenzo)curcumin | 1170354-22-9 | >95.00% | |
A semisynthetic coumarin with antiparasitic and anticancer activities | ||||
| GC91152 | Flavokawain 1i | 1098176-51-2 | >98.00% | |
A flavokawain derivative with anticancer and antiviral activities | ||||
| GC91154 | 33-BCRP Inhibitor | - | >98.00% | |
A BCRP inhibitor | ||||
| GC91403 | HR68 | 2454582-64-8 | >98.00% | |
HR68 is an anticancer agent and a derivative of the peroxisome proliferator-activated receptor (PPAR) agonist fenofibric acid . | ||||
| GC91435 | YCH1899 | - | >98.00% | |
YCH1899 is an inhibitor of poly(ADP-ribose) polymerase 1 (PARP1) and PARP2 (IC50s = 1 It is selective for PARP1 and PARP2 over PARP3, -4, -5A, -5B, -6, -7, -10, and -12 (IC50s = 1-14.1 nM). | ||||
